| Year |
Citation |
Score |
| 2020 |
Thomas ER, Zeliadt SB, Coggeshall S, Gelman H, Resnick A, Giannitrapani K, Olson J, Kligler B, Taylor SL. Does Offering Battlefield Acupuncture Lead to Subsequent Use of Traditional Acupuncture? Medical Care. 58: S108-S115. PMID 32826780 DOI: 10.1097/Mlr.0000000000001367 |
0.318 |
|
| 2020 |
Becker DJ, Rude T, Walter D, Wang C, Loeb S, Li H, Ciprut S, Kelly M, Zeliadt SB, Fagerlin A, Lepor H, Sherman S, Ravenell JE, Makarov DV. The Association of Veterans' PSA Screening Rates with Changes in USPSTF Recommendations. Journal of the National Cancer Institute. PMID 32797212 DOI: 10.1093/Jnci/Djaa120 |
0.365 |
|
| 2020 |
Ciprut SE, Kelly MD, Walter D, Hoffman R, Becker DJ, Loeb S, Sedlander E, Tenner CT, Sherman SE, Zeliadt SB, Makarov DV. A Clinical Reminder Order Check (CROC) Intervention to Improve Guideline-Concordant Imaging Practices for men with Prostate Cancer: A Pilot Study. Urology. PMID 32721517 DOI: 10.1016/J.Urology.2020.05.101 |
0.4 |
|
| 2020 |
Golden SE, Ono SS, Melzer A, Davis J, Zeliadt SB, Heffner JL, Kathuria H, Garcia-Alexander G, Slatore CG. "I already know that smoking ain't good for me": Patient and clinician perspectives on lung cancer screening decision-making discussions as a teachable moment. Chest. PMID 32304776 DOI: 10.1016/J.Chest.2020.03.061 |
0.326 |
|
| 2020 |
Becker D, Rude T, Walter D, Wang C, Loeb S, Li H, Ciprut S, Kelly M, Zeliadt S, Fagerlin A, Lepor H, Sherman S, Ravenell J, Makarov* D. PD38-03 USE OF PROSTATE SPECIFIC ANTIGEN SCREENING FOR VETERANS BEFORE, DURING, AND AFTER THE 2012 UNITED STATES PREVENTATIVE SERVICES TASK FORCE RECOMMENDATIONS The Journal of Urology. 203: e802. DOI: 10.1097/Ju.0000000000000917.03 |
0.305 |
|
| 2018 |
Greene PA, Sayre G, Heffner JL, Klein DE, Krebs P, Au DH, Zeliadt SB. Challenges to Educating Smokers About Lung Cancer Screening: a Qualitative Study of Decision Making Experiences in Primary Care. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. PMID 30173354 DOI: 10.1007/S13187-018-1420-Y |
0.321 |
|
| 2018 |
Walsh TJ, Shores MM, Krakauer CA, Forsberg CW, Fox AE, Moore KP, Korpak A, Heckbert SR, Zeliadt SB, Kinsey CE, Thompson ML, Smith NL, Matsumoto AM. Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels. Plos One. 13: e0199194. PMID 29933385 DOI: 10.1371/Journal.Pone.0199194 |
0.383 |
|
| 2018 |
Heffner JL, Krebs P, Johnson H, Greene PA, Klein DE, Feemster LC, Slatore CG, Au DH, Zeliadt SB. Smokers' Inaccurate Beliefs about the Benefits of Lung Cancer Screening. Annals of the American Thoracic Society. PMID 29877728 DOI: 10.1513/Annalsats.201804-259Rl |
0.317 |
|
| 2018 |
Zeliadt SB, Hoffman RM, Birkby G, Eberth JM, Brenner AT, Reuland DS, Flocke SA. Challenges Implementing Lung Cancer Screening in Federally Qualified Health Centers. American Journal of Preventive Medicine. PMID 29429606 DOI: 10.1016/J.Amepre.2018.01.001 |
0.325 |
|
| 2017 |
Joseph AM, Rothman AJ, Almirall D, Begnaud A, Chiles C, Cinciripini PM, Fu SS, Graham AL, Lindgren BR, Melzer AC, Ostroff JS, Seaman EL, Taylor KL, Toll BA, Zeliadt SB, et al. Lung Cancer Screening and Smoking Cessation Clinical Trials: SCALE Collaboration. American Journal of Respiratory and Critical Care Medicine. PMID 28977754 DOI: 10.1164/Rccm.201705-0909Ci |
0.324 |
|
| 2017 |
Zeliadt SB, Greene PA, Krebs P, Klein DE, Feemster LC, Au DH, Slatore CG, Heffner JL. A Proactive Telephone-Delivered Risk Communication Intervention for Smokers Participating in Lung Cancer Screening: A Pilot Feasibility Trial Journal of Smoking Cessation. 13: 137-144. DOI: 10.1017/Jsc.2017.16 |
0.33 |
|
| 2017 |
Backhus L, Reinke L, Au D, Zeliadt S, Edwards T. P2.08-004 The Importance of Patient Recall within Cancer Survivorship Care for Improved Post-Treatment Surveillance in Lung Cancer Survivors: Topic: Patient’s Voice, Patient’s Information Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.1554 |
0.365 |
|
| 2016 |
Farias AJ, Hansen RN, Zeliadt SB, Ornelas IJ, Li CI, Thompson B. The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer Patients. American Journal of Clinical Oncology. PMID 27893470 DOI: 10.1097/Coc.0000000000000351 |
0.334 |
|
| 2016 |
Crothers K, Kross E, Reisch LM, Shahrir SF, Slatore C, Zeliadt SB, Triplette M, Meza R, Elmore JG. Patients' Attitudes Regarding Lung Cancer Screening and Decision Aids: A Survey and Focus Group Study. Annals of the American Thoracic Society. PMID 27652509 DOI: 10.1513/Annalsats.201604-289Oc |
0.338 |
|
| 2016 |
Makarov DV, Sedlander E, Braithwaite RS, Sherman SE, Zeliadt S, Gross CP, Curnyn C, Shedlin M. A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer. Implementation Science : Is. 11: 118. PMID 27590603 DOI: 10.1186/S13012-016-0484-5 |
0.397 |
|
| 2016 |
Farias AJ, Ornelas IJ, Hohl SD, Zeliadt SB, Hansen RN, Li CI, Thompson B. Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 27557832 DOI: 10.1007/s00520-016-3389-6 |
0.321 |
|
| 2016 |
Farias AJ, Hansen RN, Zeliadt SB, Ornelas IJ, Li CI, Thompson B. Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis. Journal of Managed Care & Specialty Pharmacy. 22: 969-78. PMID 27459660 DOI: 10.18553/Jmcp.2016.22.8.969 |
0.331 |
|
| 2016 |
Makarov DV, Sedlander E, Curnyn C, Braithwaite RS, Gold HT, Sherman SE, Zeliadt S, Shedlin M. Mp19-14 A Qualitative Study To Understand Guideline-Discordant Use Of Imaging To Stage Incident Prostate Cancer The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2762 |
0.383 |
|
| 2015 |
Hoffman RM, Meisner A, Arap W, Barry M, Shah S, Zeliadt S, Wiggins CL. Trends in United States prostate cancer incidence rates by age and stage, 1995-2012. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26646364 DOI: 10.1158/1055-9965.Epi-15-0723 |
0.385 |
|
| 2015 |
Puttkammer N, Baseman JG, Devine EB, Valles JS, Hyppolite N, Garilus F, Honoré JG, Matheson AI, Zeliadt S, Yuhas K, Sherr K, Cadet JR, Zamor G, Pierre E, Barnhart S. An assessment of data quality in a multi-site electronic medical record system in Haiti. International Journal of Medical Informatics. PMID 26620698 DOI: 10.1016/J.Ijmedinf.2015.11.003 |
0.643 |
|
| 2015 |
Makarov DV, Hu EY, Walter D, Braithwaite RS, Sherman S, Gold HT, Zhou XA, Gross CP, Zeliadt SB. Appropriateness of Prostate Cancer Imaging among Veterans in a Delivery System without Incentives for Overutilization. Health Services Research. PMID 26423687 DOI: 10.1111/1475-6773.12395 |
0.389 |
|
| 2015 |
Backhus LM, Farjah F, Liang CJ, He H, Varghese TK, Au DH, Flum DR, Zeliadt SB. Imaging surveillance and survival for surgically resected non-small-cell lung cancer. The Journal of Surgical Research. PMID 26231974 DOI: 10.1016/J.Jss.2015.06.048 |
0.316 |
|
| 2015 |
Winters B, Plymate S, Zeliadt SB, Holt S, Zhang X, Hu E, Lin DW, Morrissey C, Wooldridge B, Gore JL, Porter MP, Wright JL. Metformin effects on biochemical recurrence and metabolic signaling in the prostate. The Prostate. PMID 26201966 DOI: 10.1002/Pros.23049 |
0.37 |
|
| 2015 |
Macleod LC, Chery LJ, Hu EY, Zeliadt SB, Holt SK, Lin DW, Porter MP, Gore JL, Wright JL. Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort. Prostate Cancer and Prostatic Diseases. 18: 190-5. PMID 25823651 DOI: 10.1038/Pcan.2015.12 |
0.334 |
|
| 2015 |
Zeliadt SB, L J, Klein DE, Sayre G, Reinke LF, Dawadi S, Au DH. Interviews With Patients Offered Lung Cancer Screening in Primary Care: Lessons in How Screening May Influence Smoking Cessation Journal of Patient-Centered Research and Reviews. 2: 108. DOI: 10.17294/2330-0698.1123 |
0.314 |
|
| 2015 |
Makarov D, Gold H, Walter D, Eugenio E, Sherman S, Gross C, Zeliadt S. Mp9-03 The Effect Of Healthcare System On Appropriateness Of Prostate Cancer Imaging: Do Patients Get Better Care In Va Or Fee-For-Service Medicare? The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.363 |
0.403 |
|
| 2015 |
Puttkammer N, Baseman J, Devine B, Hyppolite N, Honore J, Matheson A, Zeliadt S, Yuhas K, Sherr K, Cadet J, Barnhart S. An assessment of data quality in Haiti's multi-site electronic medical record system Annals of Global Health. 81: 196-197. DOI: 10.1016/J.Aogh.2015.02.952 |
0.603 |
|
| 2014 |
Puttkammer NH, Zeliadt SB, Balan JG, Baseman JG, Destiné R, Domerçant JW, Duvilaire JM, Raphael NA, Sherr K, Yuhas K, Barnhart S. Before and after the earthquake: a case study of attrition from the HIV antiretroviral therapy program in Haiti. Global Health Action. 7: 24572. PMID 28672654 DOI: 10.3402/gha.v7.24572 |
0.626 |
|
| 2014 |
Puttkammer NH, Zeliadt SB, Baseman JG, Destiné R, Wysler Domerçant J, Labbé Coq NR, Atwood Raphael N, Sherr K, Tegger M, Yuhas K, Barnhart S. Patient attrition from the HIV antiretroviral therapy program at two hospitals in Haiti. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 36: 238-47. PMID 25563149 |
0.608 |
|
| 2014 |
Puttkammer N, Zeliadt S, Balan JG, Baseman J, Destiné R, Domerçant JW, France G, Hyppolite N, Pelletier V, Raphael NA, Sherr K, Yuhas K, Barnhart S. Development of an electronic medical record based alert for risk of HIV treatment failure in a low-resource setting. Plos One. 9: e112261. PMID 25390044 DOI: 10.1371/Journal.Pone.0112261 |
0.638 |
|
| 2014 |
Backhus LM, Farjah F, Zeliadt SB, Varghese TK, Cheng A, Kessler L, Au DH, Flum DR. Predictors of imaging surveillance for surgically treated early-stage lung cancer. The Annals of Thoracic Surgery. 98: 1944-51; discussion . PMID 25282167 DOI: 10.1016/J.Athoracsur.2014.06.067 |
0.329 |
|
| 2014 |
Backhus LM, Farjah F, Varghese TK, Cheng AM, Zhou XH, Wood DE, Kessler L, Zeliadt SB. Appropriateness of imaging for lung cancer staging in a national cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3428-35. PMID 25245440 DOI: 10.1200/Jco.2014.55.6589 |
0.361 |
|
| 2014 |
Puttkammer NH, Zeliadt SB, Balan JG, Baseman JG, Destiné R, Domerçant JW, Duvilaire JM, Raphael NA, Sherr K, Yuhas K, Barnhart S. Before and after the earthquake: a case study of attrition from the HIV antiretroviral therapy program in Haiti. Global Health Action. 7: 24572. PMID 25103146 DOI: 10.3402/Gha.V7.24572 |
0.626 |
|
| 2014 |
Zeliadt SB, Loggers ET, Slatore CG, Au DH, Hebert PL, Klein GJ, Kessler LG, Backhus LM. Preoperative PET and the reduction of unnecessary surgery among newly diagnosed lung cancer patients in a community setting. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 379-85. PMID 24449594 DOI: 10.2967/Jnumed.113.124230 |
0.305 |
|
| 2014 |
Backhus LM, Farjah F, Zeliadt S, Flum DR. Profiling Hospital Performance: Adherence to Guidelines for Perioperative Lung Cancer Staging Journal of the American College of Surgeons. 219. DOI: 10.1016/J.Jamcollsurg.2014.07.075 |
0.324 |
|
| 2014 |
Puttkammer NH, Zeliadt SB, Baseman J, Destine R, Coq NRL, Domercant JW, Raphael NA, Sherr K, Yuhas K, Barnhart S. Using an electronic medical record system to identify factors associated with attrition from the HIV antiretroviral therapy program at two hospitals in Haiti Annals of Global Health. 80: 191-192. DOI: 10.1016/J.Aogh.2014.08.106 |
0.648 |
|
| 2013 |
Ramsey SD, Zeliadt SB, Blough DK, Moinpour CM, Hall IJ, Smith JL, Ekwueme DU, Fedorenko CR, Fairweather ME, Koepl LM, Thompson IM, Keane TE, Penson DF. Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences. The Journal of Sexual Medicine. 10: 3135-43. PMID 24118980 DOI: 10.1111/Jsm.12295 |
0.41 |
|
| 2013 |
Li C, Zeliadt SB, Hall IJ, Smith JL, Ekwueme DU, Moinpour CM, Penson DF, Thompson IM, Keane TE, Ramsey SD. Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1Â year after diagnosis: an economic perspective. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 3461-9. PMID 23955026 DOI: 10.1007/S00520-013-1931-3 |
0.391 |
|
| 2013 |
Wright JL, Plymate SR, Porter MP, Gore JL, Lin DW, Hu E, Zeliadt SB. Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer. Prostate Cancer and Prostatic Diseases. 16: 204-8. PMID 23459096 DOI: 10.1038/Pcan.2013.5 |
0.384 |
|
| 2013 |
Backhus LM, Hayanga AJ, Au D, Zeliadt SB. The effect of provider density on lung cancer survival among blacks and whites in the United States. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 549-53. PMID 23446202 DOI: 10.1097/Jto.0B013E318287C24C |
0.33 |
|
| 2013 |
Zeliadt SB, Hannon PA, Trivedi RB, Bonner LM, Vu TT, Simons C, Kimmie CA, Hu EY, Zipperer C, Lin DW. A preliminary exploration of the feasibility of offering men information about potential prostate cancer treatment options before they know their biopsy results Bmc Medical Informatics and Decision Making. 13. PMID 23388205 DOI: 10.1186/1472-6947-13-19 |
0.394 |
|
| 2013 |
Backhus LM, Farjah F, Varghese TK, Cheng A, Zhou XH, Wood DE, Kessler L, Zeliadt SB. Appropriateness of imaging in lung cancer in a national cohort. Journal of Clinical Oncology. 31: 7546-7546. DOI: 10.1200/Jco.2013.31.15_Suppl.7546 |
0.338 |
|
| 2012 |
Xia J, Trock BJ, Cooperberg MR, Gulati R, Zeliadt SB, Gore JL, Lin DW, Carroll PR, Carter HB, Etzioni R. Prostate cancer mortality following active surveillance versus immediate radical prostatectomy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5471-8. PMID 23008476 DOI: 10.1158/1078-0432.Ccr-12-1502 |
0.385 |
|
| 2012 |
Li C, Zeliadt SB, Hall IJ, Smith JL, Ekwueme DU, Moinpour CM, Penson DF, Thompson IM, Keane TE, Ramsey SD. Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 716-23. PMID 22867781 DOI: 10.1016/J.Jval.2012.03.003 |
0.389 |
|
| 2012 |
Ramsey SD, Zeliadt SB, Blough DK, Fedorenko CR, Fairweather ME, McDermott CL, Penson DF, Van Den Eeden SK, Hamilton AS, Arora NK. Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer. Urology. 79: 1034-41. PMID 22546381 DOI: 10.1016/J.Urology.2012.01.023 |
0.373 |
|
| 2012 |
Zeliadt SB, Buist DS, Reid RJ, Grossman DC, Ma J, Etzioni R. Biopsy follow-up of prostate-specific antigen tests. American Journal of Preventive Medicine. 42: 37-43. PMID 22176844 DOI: 10.1016/J.Amepre.2011.08.024 |
0.37 |
|
| 2012 |
McDermott CL, Blough DK, Fedorenko CR, Arora NK, Zeliadt SB, Fairweather ME, Oakley-Girvan I, Van Den Eeden SK, Ramsey SD. Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 20: 65-73. PMID 21120540 DOI: 10.1007/S00520-010-1055-Y |
0.414 |
|
| 2012 |
Wright JL, Gore JL, Porter MP, Lin DW, Hu E, Zeliadt S. 167 SERUM GLUCOSE IS ASSOCIATED WITH BIOCHEMICAL RECURRENCE IN MEN WITHOUT DIABETES TREATED FOR LOCALIZED PROSTATE CANCER Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.218 |
0.348 |
|
| 2011 |
Hayanga AJ, Zeliadt SB, Wood DE, Backhus LM. The association of obesity, smoking, and access to oncology services with cancer mortality in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 6023. PMID 28021966 DOI: 10.1200/Jco.2011.29.15_Suppl.6023 |
0.317 |
|
| 2011 |
Zeliadt SB, Sekaran NK, Hu EY, Slatore CC, Au DH, Backhus L, Wu DY, Crawford J, Lyman GH, Dale DC. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest Journal of Thoracic Oncology. 6: 1726-1732. PMID 21857253 DOI: 10.1097/Jto.0B013E31822Ada77 |
0.335 |
|
| 2011 |
Rim SH, Hall IJ, Fairweather ME, Fedorenko CR, Ekwueme DU, Smith JL, Thompson IM, Keane TE, Penson DF, Moinpour CM, Zeliadt SB, Ramsey SD. Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population. International Journal of General Medicine. 4: 481-6. PMID 21760749 DOI: 10.2147/Ijgm.S19609 |
0.378 |
|
| 2011 |
Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW. Influence of publication of US and European prostate cancer screening trials on PSA testing practices. Journal of the National Cancer Institute. 103: 520-3. PMID 21357307 DOI: 10.1093/Jnci/Djr007 |
0.39 |
|
| 2011 |
Zeliadt SB, Penson DF, Moinpour CM, Blough DK, Fedorenko CR, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE, Ramsey SD. Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. Bju International. 108: 851-6; discussion 85. PMID 21244609 DOI: 10.1111/J.1464-410X.2010.09945.X |
0.365 |
|
| 2011 |
Ramsey SD, Zeliadt SB, Fedorenko CR, Blough DK, Moinpour CM, Hall IJ, Smith JL, Ekwueme DU, Fairweather ME, Thompson IM, Keane TE, Penson DF. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions. World Journal of Urology. 29: 3-9. PMID 20959991 DOI: 10.1007/S00345-010-0602-Y |
0.401 |
|
| 2011 |
Zeliadt S, Buist D, Reid R, Grossman D, Chen S, Etzioni R. PS2-43: Prostate-Specific Antigen Tests in Clinical Practice over the Past Decade: Is the Threshold for Recommending Biopsy Dropping? Clinical Medicine & Research. 9: 146-147. DOI: 10.3121/Cmr.2011.1020.Ps2-43 |
0.351 |
|
| 2011 |
Zeliadt S, Bonner L, Trivedi R, Kimmie C, Hannon P, Vu T, Zipperer C, Porter M, Lin D. 627 A RANDOMIZED PILOT STUDY TO ASSESS ANXIETY RELATED TO DISTRIBUTING A PROSTATE CANCER TREATMENT DECISION AID PRIOR TO BIOPSY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1503 |
0.382 |
|
| 2011 |
Westerman S, Zeliadt S, Gore J, Lin D. 71 THE COST-EFFECTIVENESS OF THE DOUBLE BENEFIT OF 5-ALPHA-REDUCTASE INHIBITOR (5ARI) CHEMOPREVENTION ON BOTH UNDISCLOSED GENITOURINARY SYMPTOMS AND PROSTATE CANCER Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.135 |
0.336 |
|
| 2010 |
Zeliadt SB, Ramsey SD. Cost-effectiveness of prostate cancer chemoprevention among high-risk men. Expert Review of Pharmacoeconomics & Outcomes Research. 10: 505-8. PMID 20950065 DOI: 10.1586/Erp.10.63 |
0.407 |
|
| 2010 |
Zeliadt SB, Hoffman RM, Etzioni R, Ginger VA, Lin DW. What happens after an elevated PSA test: the experience of 13,591 veterans. Journal of General Internal Medicine. 25: 1205-10. PMID 20697965 DOI: 10.1007/S11606-010-1468-9 |
0.344 |
|
| 2010 |
Ramsey SD, Zeliadt SB, Arora NK, Blough DK, Penson DF, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Fedorenko CR, Potosky AL. Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. The Journal of Urology. 184: 120-5. PMID 20478590 DOI: 10.1016/J.Juro.2010.03.023 |
0.397 |
|
| 2010 |
Zeliadt SB, Moinpour CM, Blough DK, Penson DF, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE, Ramsey SD. Preliminary treatment considerations among men with newly diagnosed prostate cancer. The American Journal of Managed Care. 16: e121-30. PMID 20455638 |
0.302 |
|
| 2010 |
Zeliadt SB, Ramsey SD, Van Den Eeden SK, Hamilton AS, Oakley-Girvan I, Penson DF, Fairweather ME, Arora NK, Potosky AL. Patient recruitment methods to evaluate treatment decision making for localized prostate cancer. American Journal of Clinical Oncology. 33: 381-6. PMID 20010079 DOI: 10.1097/Coc.0B013E3181B215D5 |
0.404 |
|
| 2010 |
Ramsey SD, Zeliadt SB, Richardson LC, Pollack LA, Linden H, Blough DK, Cheteri MK, Tock L, Nagy K, Anderson N. Discontinuation of radiation treatment among medicaid-enrolled women with local and regional stage breast cancer. The Breast Journal. 16: 20-7. PMID 19929888 DOI: 10.1111/J.1524-4741.2009.00865.X |
0.308 |
|
| 2010 |
Ramsey SD, Zeliadt SB, Blough DK, Lopez K, Buchwald D. Cancer Care of American Indians and Alaska Natives and Other Racial Groups Enrolled in Public and Private Insurance Plans Poverty & Public Policy. 2: 17-35. DOI: 10.2202/1944-2858.1024 |
0.355 |
|
| 2010 |
Zeliadt SB, Sekaran NK, Slatore CG, Au DH, Wu DY, Crawford J, Lyman GH, Dale DC. Comparison of the Veterans Affairs Oncology Registry and the SEER Cancer Registry among patients with lung cancer. Journal of Clinical Oncology. 28: 6056-6056. DOI: 10.1200/Jco.2010.28.15_Suppl.6056 |
0.395 |
|
| 2010 |
Ramsey S, Zeliadt S, Blough D, Fedorenko C, Moinpour C, Hall I, Smith JL, Ekwueme D, Fairweather M, Thompson I, Keane T, Penson D. Pcn145 A Comparison Of Physician And Patient Decision Making For First Versus Second Opinions Among Men With Local Stage Prostate Cancer Value in Health. 13. DOI: 10.1016/S1098-3015(10)72233-6 |
0.391 |
|
| 2009 |
Ramsey SD, Zeliadt SB, Arora NK, Potosky AL, Blough DK, Hamilton AS, Van Den Eeden SK, Oakley-Girvan I, Penson DF. Access to information sources and treatment considerations among men with local stage prostate cancer. Urology. 74: 509-15. PMID 19589564 DOI: 10.1016/J.Urology.2009.01.090 |
0.382 |
|
| 2009 |
Ramsey S, McDermott C, Zeliadt S, Blough D, Fedorenko C, Arora N, Penson D, Oakley-Girvan I, Hamilton A, Van Den Eeden S, Potosky A. PCN136 COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) USE AMONG LOCAL STAGE PROSTATE CANCER PATIENTS: TYPES, FACTORS ASSOCIATED WITH USE AND PERCEIVED BENEFITS Value in Health. 12: A283. DOI: 10.1016/S1098-3015(10)74386-2 |
0.396 |
|
| 2009 |
Zeliadt SB, Ginger VAT, Etzioni R, Lin DW. FOLLOW UP AND BIOPSY PATTERNS AFTER ELEVATED PROSTATE SPECIFIC ANTIGEN (PSA) TESTS Journal of Urology. 181: 751-752. DOI: 10.1016/S0022-5347(09)62095-4 |
0.324 |
|
| 2009 |
Penson DF, Zeliadt SB, Moinpour CM, Hall IJ, Smith JL, Fedorenko CR, Thompson IM, Keane TE, Ramsey SD. Race And Shared Decision Making Among Prostate Cancer Patients, Family Members And Physicians The Journal of Urology. 181: 26-26. DOI: 10.1016/S0022-5347(09)60085-9 |
0.369 |
|
| 2008 |
Zeliadt SB, Ramsey SD, Potosky AL, Arora NK, Blough DK, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Penson DF. Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients. The Patient. 1: 189. PMID 20119493 DOI: 10.2165/1312067-200801030-00006 |
0.362 |
|
| 2008 |
Ramsey SD, Zeliadt SB, Richardson LC, Pollack L, Linden H, Blough DK, Anderson N. Disenrollment from medicaid after recent cancer diagnosis Medical Care. 46: 49-57. PMID 18162855 DOI: 10.1097/Mlr.0B013E318158Ec7F |
0.382 |
|
| 2008 |
Ramsey S, Zeliadt S, Moinpour C, Hall I, Lee J, Ekwueme D, Thompson I, Keane T, Fedorenko C, Penson D. Pcn89 Race And Shared Decision Making Among Prostate Cancer Patients, Family Members And Physicians Value in Health. 11. DOI: 10.1016/S1098-3015(10)66626-0 |
0.369 |
|
| 2007 |
Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF. On the Importance of Race, Socioeconomic Status and Comorbidity When Evaluating Quality of Life in Men With Prostate Cancer Journal of Urology. 177: 1992-1999. PMID 17509278 DOI: 10.1016/J.Juro.2007.01.138 |
0.331 |
|
| 2007 |
Zeliadt SB, Penson DF. Pharmacoeconomics of available treatment options for metastatic prostate cancer. Pharmacoeconomics. 25: 309-27. PMID 17402804 DOI: 10.2165/00019053-200725040-00004 |
0.419 |
|
| 2007 |
Zeliadt SB, Etzioni R, Ramsey SD, Penson DF, Potosky AL. Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Medical Care. 45: 154-9. PMID 17224778 DOI: 10.1097/01.Mlr.0000241044.09778.3F |
0.389 |
|
| 2006 |
Zeliadt SB, Potosky AL, Penson DF, Etzioni R. Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 66: 395-402. PMID 16904843 DOI: 10.1016/J.Ijrobp.2006.04.048 |
0.379 |
|
| 2005 |
Zeliadt SB, Etzioni RD, Penson DF, Thompson IM, Ramsey SD. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer. The American Journal of Medicine. 118: 850-7. PMID 16084177 DOI: 10.1016/J.Amjmed.2005.03.001 |
0.391 |
|
| 2005 |
Zeliadt SB, Etzioni R, Kristal AR. Estimated impact of the prostate cancer prevention trial on population mortality. Cancer. 104: 1556-7; author reply. PMID 16015625 DOI: 10.1002/Cncr.21344 |
0.354 |
|
| 2005 |
Ramsey S, Zeliadt S, Hall I, Ekwueme D. Pcn44 Health Related Quality Of Life Evaluations In Prostate Cancer: Who'S Being Studied? Value in Health. 8. DOI: 10.1016/S1098-3015(10)67282-8 |
0.363 |
|
| 2004 |
Zeliadt SB, Etzioni R, Penson DF, Ramsey SD. Cost-effectiveness and lifetime implications of using finasteride to reduce prostate cancer incidence and mortality. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1028. PMID 28014704 DOI: 10.1200/Jco.2004.22.14_Suppl.1028 |
0.376 |
|
| 2004 |
Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 64: 1171-6. PMID 15596192 DOI: 10.1016/J.Urology.2004.07.037 |
0.42 |
|
| 2004 |
Shaw PA, Etzioni R, Zeliadt SB, Mariotto A, Karnofski K, Penson DF, Weiss NS, Feuer EJ. An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States. American Journal of Epidemiology. 160: 1059-69. PMID 15561985 DOI: 10.1093/Aje/Kwh336 |
0.382 |
|
| 2004 |
Bermejo C, Kristal AR, Zeliadt SB, Ramsey S, Thompson IM. Localized prostate cancer: Quality of life meets Whitmore's legacy Journal of the National Cancer Institute. 96: 1348-1349. PMID 15367562 DOI: 10.1093/Jnci/Djh282 |
0.43 |
|
| 2003 |
Zeliadt SB, Penson DF, Albertsen PC, Concato J, Etzioni RD. Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis Cancer. 98: 496-503. PMID 12879465 DOI: 10.1002/Cncr.11492 |
0.379 |
|
| Show low-probability matches. |